MeMed Severity™ has received FDA Breakthrough Device Designation as a host-response test designed to predict severe outcomes up to 72 hours and mortality 14 days in advance in patients with acute ...
The company's BV Flex test measures patient immune proteins in capillary blood samples to determine whether an individual has a bacterial or viral infection.
The kidneys contain millions of microscopic blood vessels known as peritubular capillaries. These vessels recapture helpful nutrients like glucose and minerals and return them to your bloodstream for ...
Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...
Background Blood biomarkers exhibit promising potential for monitoring brain injuries. Nevertheless, there exists a dearth of understanding concerning the influence of various impact characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results